{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:28:04Z","timestamp":1791689284167,"version":"4.3.4"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000015","name":"Canadian Cancer Society Research Institute","doi-asserted-by":"publisher","award":["704036"],"award-info":[{"award-number":["704036"]}],"id":[{"id":"10.13039\/501100000015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ypmed.2018.08.034","type":"journal-article","created":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T06:28:14Z","timestamp":1535696894000},"page":"40-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: A mixed methods research synthesis"],"prefix":"10.1016","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1886-6390","authenticated-orcid":false,"given":"Ovidiu","family":"Tatar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anila","family":"Naz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4849-8616","authenticated-orcid":false,"given":"Samara","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2214-8263","authenticated-orcid":false,"given":"Gilla K.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3835-937X","authenticated-orcid":false,"given":"Gregory","family":"Zimet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Gilca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1728-8085","authenticated-orcid":false,"given":"Monika","family":"Janda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6313-4976","authenticated-orcid":false,"given":"Jessica","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Daley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeev","family":"Rosberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2018.08.034_bb0005","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1472-6874-14-86","article-title":"Analysis of three strategies to increase screening coverage for cervical cancer in the general population of women aged 60 to 70\u202fyears: the CRICERVA study","volume":"14","author":"Acera","year":"2014","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.ypmed.2018.08.034_bb0010","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ypmed.2016.11.023","article-title":"Sexual orientation and sexual health services utilization among women in the United States","volume":"95","author":"Agenor","year":"2017","journal-title":"Prev. Med."},{"key":"10.1016\/j.ypmed.2018.08.034_bb0015","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1186\/s12889-015-2360-7","article-title":"Factors affecting attendance to cervical cancer screening among women in the Paracentral Region of El Salvador: a nested study within the CAPE HPV screening program","volume":"15","author":"Alfaro","year":"2015","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ypmed.2018.08.034_bb0020","doi-asserted-by":"crossref","first-page":"c1804","DOI":"10.1136\/bmj.c1804","article-title":"Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme","volume":"340","author":"Anttila","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ypmed.2018.08.034_bb0025","author":"Australian Government Department of Health"},{"issue":"3","key":"10.1016\/j.ypmed.2018.08.034_bb0030","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/jwh.2015.5326","article-title":"Discontent and confusion: primary care providers' opinions and understanding of current cervical cancer screening recommendations","volume":"25","author":"Boone","year":"2016","journal-title":"J. Women's Health (Larchmt)"},{"key":"10.1016\/j.ypmed.2018.08.034_bb0035","first-page":"272","article-title":"ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World","author":"Bruni","year":"2017"},{"issue":"9601","key":"10.1016\/j.ypmed.2018.08.034_bb0040","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(07)61450-0","article-title":"Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial","volume":"370","author":"Bulkmans","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ypmed.2018.08.034_bb0045","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/1471-2458-14-360","article-title":"Does the primary screening test influence women's anxiety and intention to screen for cervical cancer? A randomized survey of Norwegian women","volume":"14","author":"Burger","year":"2014","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1016\/j.ypmed.2018.08.034_bb0050","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/CEJ.0000000000000325","article-title":"Gynecologists and human papillomavirus DNA testing: exploring knowledge, attitudes, and practice in Italy","volume":"26","author":"Caglioti","year":"2017","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.ypmed.2018.08.034_bb0055","series-title":"Health Behavior and Health Education: Theory, Research and Practice","first-page":"45","article-title":"The health belief model","author":"Champion","year":"2008"},{"issue":"2","key":"10.1016\/j.ypmed.2018.08.034_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.10.006","article-title":"Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system","volume":"216","author":"Chao","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ypmed.2018.08.034_bb0065","series-title":"Types of Mixed Methods Designs. Research Design: Qualitative, Quantitative, and Mixed Methods Approaches","first-page":"220","volume":"5\u20137","author":"Creswell","year":"2014"},{"issue":"9895","key":"10.1016\/j.ypmed.2018.08.034_bb0070","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","article-title":"Human papillomavirus and cervical cancer","volume":"382","author":"Crosbie","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ypmed.2018.08.034_bb0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1369-7625.2011.00707.x","article-title":"What Australian women want and when they want it: cervical screening testing preferences, decision-making styles and information needs","volume":"16","author":"Dieng","year":"2013","journal-title":"Health Expect."},{"issue":"3","key":"10.1016\/j.ypmed.2018.08.034_bb0080","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1136\/sextrans-2013-051402","article-title":"Knowledge of human papillomavirus (HPV) testing in the USA, the UK and Australia: an international survey","volume":"90","author":"Dodd","year":"2014","journal-title":"Sex. Transm. Infect."},{"issue":"8","key":"10.1016\/j.ypmed.2018.08.034_bb0085","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.ejca.2015.03.008","article-title":"Cervical cancer screening in Europe: quality assurance and organisation of programmes","volume":"51","author":"Elfstrom","year":"2015","journal-title":"Eur. J. Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.ypmed.2018.08.034_bb0090","first-page":"S62-S8","article-title":"Cervical cancer screening of HPV vaccinated populations: cytology, molecular testing, both or none","volume":"76","author":"El-Zein","year":"2016","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.ypmed.2018.08.034_bb0095","first-page":"226","article-title":"Attitude to human papillomavirus deoxyribonucleic acid-based cervical cancer screening in antenatal care in Nigeria: a qualitative study","volume":"5","author":"Filade","year":"2017","journal-title":"Front."},{"key":"10.1016\/j.ypmed.2018.08.034_bb0100","article-title":"Five myths about the new cervical screening program that refuse to die [Internet]","author":"Foran","year":"2017","journal-title":"The Conversation"},{"issue":"6","key":"10.1016\/j.ypmed.2018.08.034_bb0105","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.arcmed.2009.06.003","article-title":"The expected impact of HPV vaccination on the accuracy of cervical cancer screening: the need for a paradigm change","volume":"40","author":"Franco","year":"2009","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.ypmed.2018.08.034_bb0110","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ypmed.2016.11.028","article-title":"Understanding women's hesitancy to undergo less frequent cervical cancer screening","volume":"95","author":"Gerend","year":"2017","journal-title":"Prev. Med."},{"issue":"2","key":"10.1016\/j.ypmed.2018.08.034_bb0115","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s11135-011-9538-6","article-title":"Mixed methods research synthesis: definition, framework, and potential","volume":"47","author":"Heyvaert","year":"2011","journal-title":"Qual. Quant."},{"issue":"9","key":"10.1016\/j.ypmed.2018.08.034_bb0120","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s11606-008-0633-x","article-title":"Preferences for human papillomavirus testing with routine cervical cancer screening in diverse older women","volume":"23","author":"Huang","year":"2008","journal-title":"J. Gen. Intern. Med."},{"issue":"2","key":"10.1016\/j.ypmed.2018.08.034_bb0125","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ygyno.2014.12.022","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance","volume":"136","author":"Huh","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.ypmed.2018.08.034_bb0130","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1016\/j.jcv.2015.10.026","article-title":"Primary HPV DNA based cervical cancer screening at 25\u202fyears: views of young Australian women aged 16\u201328\u202fyears","volume":"76","author":"Jayasinghe","year":"2016","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.ypmed.2018.08.034_bb0135","series-title":"Papillomavirus Research","first-page":"22","article-title":"European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination","volume":"1","author":"von Karsa","year":"2015"},{"issue":"12","key":"10.1016\/j.ypmed.2018.08.034_bb0140","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/pon.1706","article-title":"De-stigmatising human papillomavirus in the context of cervical cancer: a randomised controlled trial","volume":"19","author":"Kwan","year":"2010","journal-title":"Psychooncology"},{"issue":"5","key":"10.1016\/j.ypmed.2018.08.034_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153367","article-title":"Perceptions and experiences of human papillomavirus (HPV) infection and testing among low-income Mexican women","volume":"11","author":"Leon-Maldonado","year":"2016","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.ypmed.2018.08.034_bb0150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1258\/jms.2008.008011","article-title":"Sociodemographic predictors of HPV testing and vaccination acceptability: results from a population-representative sample of British women","volume":"15","author":"Marlow","year":"2008","journal-title":"J. Med. Screen."},{"issue":"1","key":"10.1016\/j.ypmed.2018.08.034_bb0155","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1783\/147118909787072432","article-title":"Human papillomavirus (HPV) information needs: a theoretical framework","volume":"35","author":"Marlow","year":"2009","journal-title":"J. Fam. Plann. Reprod. Health Care"},{"issue":"5","key":"10.1016\/j.ypmed.2018.08.034_bb0160","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.vaccine.2012.11.083","article-title":"Knowledge of human papillomavirus (HPV) and HPV vaccination: an international comparison","volume":"31","author":"Marlow","year":"2013","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ypmed.2018.08.034_bb0165","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"de Martel","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"7716","key":"10.1016\/j.ypmed.2018.08.034_bb0170","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ypmed.2018.08.034_bb0175","series-title":"Health Behavior: Theory, Research, and Practice","first-page":"95","article-title":"Theory of reasoned action, theory of planned behavior, and the integrated behavioral model","author":"Montano","year":"2015"},{"issue":"12","key":"10.1016\/j.ypmed.2018.08.034_bb0180","doi-asserted-by":"crossref","first-page":"880","DOI":"10.7326\/0003-4819-156-12-201206190-00424","article-title":"Screening for cervical cancer: U.S. preventive services task force recommendation statement","volume":"156","author":"Moyer","year":"2012","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ypmed.2018.08.034_bb0185","author":"National Screening Unit"},{"issue":"16","key":"10.1016\/j.ypmed.2018.08.034_bb0190","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa073204","article-title":"Human papillomavirus and Papanicolaou tests to screen for cervical cancer","volume":"357","author":"Naucler","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.ypmed.2018.08.034_bb0195","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2471\/BLT.06.031195","article-title":"Determinants of women's participation in cervical cancer screening trail, Maharashtra, India","volume":"85","author":"Nene","year":"2007","journal-title":"Bull. World Health Organ."},{"issue":"12","key":"10.1016\/j.ypmed.2018.08.034_bb0200","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1002\/ijc.28324","article-title":"Women's intentions to receive cervical cancer screening with primary human papillomavirus testing","volume":"133","author":"Ogilvie","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"213","key":"10.1016\/j.ypmed.2018.08.034_bb0205","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12889-016-2865-8","article-title":"Correlates of women's intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval","volume":"16","author":"Ogilvie","year":"2016","journal-title":"BMC Public Health"},{"issue":"9686","key":"10.1016\/j.ypmed.2018.08.034_bb0210","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ypmed.2018.08.034_bb0215","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/LGT.0b013e31818a53f0","article-title":"Assessing the role of education in women's knowledge and acceptance of adjunct high-risk human papillomavirus testing for cervical cancer screening","volume":"13","author":"Papa","year":"2009","journal-title":"J. Low. Genit. Tract Dis."},{"key":"10.1016\/j.ypmed.2018.08.034_bb0220","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ypmed.2016.07.017","article-title":"Extending and validating a human papillomavirus (HPV) knowledge measure in a national sample of Canadian parents of boys","volume":"91","author":"Perez","year":"2016","journal-title":"Prev. Med."},{"issue":"36","key":"10.1016\/j.ypmed.2018.08.034_bb0225","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1016\/j.vaccine.2017.07.043","article-title":"Untangling the psychosocial predictors of HPV vaccination decision-making among parents of boys","volume":"35","author":"Perez","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.ypmed.2018.08.034_bb0230","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-publhealth-032013-182440","article-title":"Combining the power of stories and the power of numbers: mixed methods research and mixed studies reviews","volume":"35","author":"Pluye","year":"2014","journal-title":"Annu. Rev. Public Health"},{"key":"10.1016\/j.ypmed.2018.08.034_bb0235","author":"Public Health England"},{"issue":"1","key":"10.1016\/j.ypmed.2018.08.034_bb0240","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1470-2045(11)70296-0","article-title":"Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial","volume":"13","author":"Rijkaart","year":"2012","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.ypmed.2018.08.034_bb0245","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/2150131915624869","article-title":"Changes in knowledge and beliefs about human papillomavirus and cervical cancer screening intervals in low-income women after an educational intervention","volume":"7","author":"Roland","year":"2016","journal-title":"J. Prim. Care Community Health"},{"issue":"3","key":"10.1016\/j.ypmed.2018.08.034_bb0250","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol."},{"issue":"9916","key":"10.1016\/j.ypmed.2018.08.034_bb0255","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ypmed.2018.08.034_bb0260","first-page":"29","article-title":"Defining and designing mixed research synthesis studies","volume":"13","author":"Sandelowski","year":"2006","journal-title":"Res Sch."},{"issue":"4","key":"10.1016\/j.ypmed.2018.08.034_bb0265","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/1558689811427913","article-title":"Mapping the mixed methods-mixed research synthesis terrain","volume":"6","author":"Sandelowski","year":"2012","journal-title":"J. Mixed Methods Res."},{"issue":"14","key":"10.1016\/j.ypmed.2018.08.034_bb0270","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","article-title":"HPV screening for cervical cancer in rural India","volume":"360","author":"Sankaranarayanan","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.ypmed.2018.08.034_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185669","article-title":"Examining word association networks: a cross-country comparison of women's perceptions of HPV testing and vaccination","volume":"12","author":"Schmid","year":"2017","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.ypmed.2018.08.034_bb0280","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/AOG.0000000000000638","article-title":"Patient concerns about human papillomavirus testing and 5-year intervals in routine cervical cancer screening","volume":"125","author":"Silver","year":"2015","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.ypmed.2018.08.034_bb0285","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1365-2753.2011.01662.x","article-title":"Reviewing studies with diverse designs: the development and evaluation of a new tool","volume":"18","author":"Sirriyeh","year":"2012","journal-title":"J. Eval. Clin. Pract."},{"key":"10.1016\/j.ypmed.2018.08.034_bb0290","author":"The American Cancer Society medical and editorial content team"},{"key":"10.1016\/j.ypmed.2018.08.034_bb0295","author":"The American Congress of Obstetricians and Gynecologists"},{"key":"10.1016\/j.ypmed.2018.08.034_bb0300","author":"The Canadian Partnership Against Cancer"},{"key":"10.1016\/j.ypmed.2018.08.034_bb0305","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ypmed.2016.11.029","article-title":"Introduction of molecular HPV testing as the primary technology in cervical cancer screening: acting on evidence to change the current paradigm","volume":"98","author":"Tota","year":"2017","journal-title":"Prev. Med."},{"issue":"5","key":"10.1016\/j.ypmed.2018.08.034_bb0310","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1177\/1049732308315734","article-title":"HPV and cervical cancer testing and prevention: knowledge, beliefs, and attitudes among Hispanic women","volume":"18","author":"Vanslyke","year":"2008","journal-title":"Qual. Health Res."},{"issue":"1","key":"10.1016\/j.ypmed.2018.08.034_bb0315","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.ypmed.2018.08.034_bb0320","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.bjc.6602312","article-title":"Making sense of information about HPV in cervical screening: a qualitative study","volume":"92","author":"Waller","year":"2005","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.ypmed.2018.08.034_bb0325","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ypmed.2012.10.028","article-title":"Validation of a measure of knowledge about human papillomavirus (HPV) using item response theory and classical test theory","volume":"56","author":"Waller","year":"2013","journal-title":"Prev. Med."},{"key":"10.1016\/j.ypmed.2018.08.034_bb0330","article-title":"Delays and confusion cloud roll-out of new cervical cancer screening program [Internet]","author":"Williams","year":"2017","journal-title":"The Conversation"}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743518302652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743518302652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T18:38:06Z","timestamp":1751827086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743518302652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":66,"alternative-id":["S0091743518302652"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2018.08.034","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: A mixed methods research synthesis","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2018.08.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}